14:00 EST ReShape CEO says Lap-Band 2.0’s PMA supplement approval ‘huge’
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RSLS:
- ReShape engages Maxim Group to identify M&A partnership alternatives
- ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
- ReShape Lifesciences: FDA approves a PMA supplement for Lap-Band 2.0 FLEX
- ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX
- ReShape Lifesciences price target lowered to $1 from $4 at Maxim